CompletedNot Applicable

Effects of Using Custom Photobiomodulation Therapy for the Treatment of Osteoarthritis of the Fingers and Rhizarthrosis

Brazil46 participantsStarted 2021-08-25

Plain-language summary

Osteoarthrosis (OA), a multifactorial degenerative process, is responsible for joint pain and functional limitation. In the hand, more specifically in the proximal and distal interphalangeal joints of the fingers, it is one of the sites of greatest manifestation of the disease. Numerous treatments, whether drug, rehabilitation or surgery, have been proposed with the aim of both interrupting the natural evolution of the disease and alleviating or stopping the symptoms. This study aims to evaluate the effectiveness of personalized Photobiomodulation Therapy (PBT) with regard to alleviating symptoms and improving the quality of life of these patients with the disease.

Who can participate

Age range40 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinical and radiological diagnosis of OA of the fingers of the hand and Rizarthrosis * Patients with pain for at least 3 months * Patients undergoing treatment and rehabilitation for finger OA and rhizarthrosis * Patient with good understanding of the Portuguese language who agrees to participate and sign the ICF Exclusion Criteria: * Posttraumatic arthritic changes * Systemic inflammatory arthritis (Rheumatoid Arthritis, Lupus Erythematosus, Psoriasis…) * Patients with local or systemic, acute or chronic infections

What they're measuring

Change from Baseline Pain at

Timeframe: 4 weeks and 2 months

Change from Baseline Arm, Shoulder and Hand Disability

Timeframe: 4 weeks and 2 months

Trial details

NCT IDNCT05041231

SponsorVita Care

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-31

View on ClinicalTrials.gov More Osteoarthritis trials